These results underscore the vital role of hepatic FXR-SERCA2 signaling in protecting the liver from ER stress-related injuries and in enabling AT-II to effectively combat NAFLD and IR. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.